logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-4. Demographic characteristics of clients entering treatment, 2011 or most recent year available

Part (iii) New clients by country and age (%)

CountryYearMean age%%Age Age
Age <25Age 35+known (n)unknown
Belgium201128442322451
Bulgaria20112829829936
Czech Republic2011264912448725
Denmark201127541818470
Germany20112748181859753
Estonia2011273710163:
Ireland201026511437355
Greece201132233425720
Spain20103130322676441
France20112751171115834
Italy201132293633571108
Cyprus20112659114440
Latvia(1)20112845183860
Lithuania2011312426251:
Luxembourg2011:::::
Hungary201125571032220
Malta20112748171967
Netherlands201129422576710
Austria201127541515880
Poland201024606364:
Portugal(2)201134254422650
Romania2011294617113412
Slovenia2011293314207:
Slovakia201126491110370
Finland20112749152490
Sweden2011:::::
United Kingdom(3)2010303830475651
Croatia20112753191151:
Turkey201126501210831
Norway2011:::::
Total303827174251324
 

Notes:

: Indicates no data available

Percentages are of clients whose age is known (n)

(1) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(2) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(3) Data are from 1st of April 2010 to 31st March 2011.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2012 — TDI tables V. 1.0-2012 See Table TDI-0 for details on sources.

Page last updated: Friday, 26 April 2013